{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:35:23Z","timestamp":1791362123443,"version":"4.3.1"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.prp.2025.155932","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T04:43:06Z","timestamp":1743396186000},"page":"155932","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The role of endothelin and its receptors in cardiomyopathy: From molecular mechanisms to therapeutic insights"],"prefix":"10.1016","volume":"269","author":[{"given":"Nandini","family":"Dubey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aanchal","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahsas","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Vishwakarma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagriti","family":"Bhatiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dharamvir Singh","family":"Arya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harlokesh Narayan","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2025.155932_bib1","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000001250","article-title":"2024 AHA\/ACC\/AMSSM\/HRS\/PACES\/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Ommen","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.prp.2025.155932_bib2","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/eurheartj\/ehv727","article-title":"Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases","volume":"37","author":"Pinto","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.prp.2025.155932_bib3","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41572-019-0084-1","article-title":"Dilated cardiomyopathy","volume":"5","author":"Schultheiss","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.prp.2025.155932_bib4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.25259\/NMJI_450_21","article-title":"Epidemiology of heart failure in rural Chhattisgarh, India","volume":"36","author":"Kole","year":"2023","journal-title":"Natl. Med J. India"},{"key":"10.1016\/j.prp.2025.155932_bib5","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/j.amjcard.2023.10.073","article-title":"Advances in the management of hypertrophic cardiomyopathy leading to low disease-related mortality in 2023","volume":"212S","author":"Maron","year":"2024","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.prp.2025.155932_bib6","first-page":"52","article-title":"Reverse remodeling in Dilated Cardiomyopathy: Insights and future perspectives","volume":"Vasc. 18","author":"Merlo","year":"2018","journal-title":"Int J. Cardiol. Heart"},{"key":"10.1016\/j.prp.2025.155932_bib7","doi-asserted-by":"crossref","unstructured":"V. Paris De, F. Biondi, D. Stolfo, et al., Pathophysiology. In: Sinagra G., Merlo M., Pinamonti B., (ed) Dilated cardiomyopathy: From genetics to clinical management, Springer. Chapter 3, 2019..","DOI":"10.1007\/978-3-030-13864-6_3"},{"key":"10.1016\/j.prp.2025.155932_bib8","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0140-6736(16)31713-5","article-title":"Dilated cardiomyopathy","volume":"390","author":"Weintraub","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.prp.2025.155932_bib9","article-title":"Biochemical and structural imaging of remodeled myocardium","volume":"28","author":"Mekkaoui","year":"2022","journal-title":"Curr. Opin. Physiol."},{"key":"10.1016\/j.prp.2025.155932_bib10","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1253\/circj.CJ-22-0696","article-title":"Japanese Circulation Society Joint Working Group. JCS 2023 Guideline on the Diagnosis and Treatment of Myocarditis","volume":"87","author":"Nagai","year":"2023","journal-title":"Circ. J."},{"key":"10.1016\/j.prp.2025.155932_bib11","doi-asserted-by":"crossref","DOI":"10.1242\/dev.201786","article-title":"Endothelin signaling in development","volume":"150","author":"Kanai","year":"2023","journal-title":"Development"},{"key":"10.1016\/j.prp.2025.155932_bib12","first-page":"759","article-title":"Endothelin and the cardiovascular system: the long journey and where we are going","volume":"11","author":"Haryono","year":"2022","journal-title":"Biol. (Basel)"},{"key":"10.1016\/j.prp.2025.155932_bib13","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/332411a0","article-title":"A novel potent vasoconstrictor peptide produced by vascular endothelial cells","volume":"332","author":"Yanagisawa","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.prp.2025.155932_bib14","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jchf.2017.02.021","article-title":"Long-term effect of endothelin receptor antagonism with bosentan on the morbidity and mortality of patients with severe chronic heart failure","volume":"5","author":"Packer","year":"2017","journal-title":"Prim. Results ENABLE Trials, JACC Heart Fail"},{"key":"10.1016\/j.prp.2025.155932_bib15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/01.hjh.0000917496.33970.53","article-title":"Endothelin type A receptor blockade attenuates aorto-caval fistula-induced heart failure in rats with angiotensin II-dependent hypertension","volume":"41","author":"Kala","year":"2023","journal-title":"J. Hypertens."},{"key":"10.1016\/j.prp.2025.155932_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tcm.2019.01.007","article-title":"Endothelin-1 levels and cardiovascular events","volume":"30","author":"Jankowich","year":"2020","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.prp.2025.155932_bib17","first-page":"143","article-title":"Endothelin-1","volume":"77","author":"Houde","year":"2016","journal-title":"Biosynth., Signal. Vasoreactivity, Adv. Pharm."},{"key":"10.1016\/j.prp.2025.155932_bib18","doi-asserted-by":"crossref","first-page":"11295","DOI":"10.3390\/ijms241411295","article-title":"Endothelin-1 in health and disease","volume":"24","author":"Banecki","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.prp.2025.155932_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.00060.2009","article-title":"Regulation of blood pressure and salt homeostasis by endothelin","volume":"91","author":"Kohan","year":"2011","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.prp.2025.155932_bib20","doi-asserted-by":"crossref","DOI":"10.1097\/00005344-199800001-00012","article-title":"Characterization of site-directed antisera against endothelin-converting enzymes","volume":"31","author":"Mockridge","year":"1998","journal-title":"J. Cardiovasc Pharm."},{"key":"10.1016\/j.prp.2025.155932_bib21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1161\/01.RES.86.4.377","article-title":"Selective upregulation of cardiac endothelin system in patients with ischemic but not idiopathic dilated cardiomyopathy: endothelin-1 system in the human failing heart","volume":"86","author":"Serneri","year":"2000","journal-title":"Circ. Res"},{"key":"10.1016\/j.prp.2025.155932_bib22","series-title":"Nathanne, Chapter 25- The Endothelin System","first-page":"141","author":"Schiffrin","year":"2023"},{"key":"10.1016\/j.prp.2025.155932_bib23","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/348730a0","article-title":"Cloning and expression of a cDNA encoding an endothelin receptor","volume":"348","author":"Arai","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.prp.2025.155932_bib24","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/s41569-019-0176-3","article-title":"Endothelins in cardiovascular biology and therapeutics","volume":"16","author":"Dhaun","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.prp.2025.155932_bib25","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0006-291X(91)91806-N","article-title":"Molecular cloning of a non-isopeptide-selective human endothelin receptor","volume":"178","author":"Ogawa","year":"1991","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.prp.2025.155932_bib26","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1161\/HYPERTENSIONAHA.119.12105","article-title":"Endothelin: 30 years from discovery to therapy","volume":"74","author":"Barton","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.prp.2025.155932_bib27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0031-6997(25)06781-X","article-title":"International Union of Pharmacology nomenclature of endothelin receptors","volume":"46","author":"Masaki","year":"1994","journal-title":"Pharm. Rev."},{"key":"10.1016\/j.prp.2025.155932_bib28","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1124\/pr.54.2.219","article-title":"International Union of Pharmacology. XXIX. Update on endothelin receptor nomenclature","volume":"54","author":"Davenport","year":"2002","journal-title":"Pharm. Rev."},{"key":"10.1016\/j.prp.2025.155932_bib29","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1124\/pr.115.011833","article-title":"Endothelin","volume":"68","author":"Davenport","year":"2016","journal-title":"Pharm. Rev."},{"key":"10.1016\/j.prp.2025.155932_bib30","doi-asserted-by":"crossref","first-page":"4956","DOI":"10.1038\/s41598-017-05365-2","article-title":"Characterisation of preproendothelin-1 derived peptides identifies Endothelin-Like Domain Peptide as a modulator of Endothelin-1","volume":"7","author":"Yuzugulen","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2025.155932_bib31","doi-asserted-by":"crossref","first-page":"R254","DOI":"10.1152\/ajpregu.00584.2009","article-title":"Endothelin receptors: what's new and what do we need to know?","volume":"298","author":"Watts","year":"2010","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.prp.2025.155932_bib32","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1038\/s41467-023-36998-9","article-title":"Structural basis of peptide recognition and activation of endothelin receptors","volume":"14","author":"Ji","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.prp.2025.155932_bib33","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1254\/jphs.13R02CR","article-title":"Endothelin receptor signaling: new insight into its regulatory mechanisms","volume":"123","author":"Horinouchi","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.prp.2025.155932_bib34","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/0196-9781(94)90213-5","article-title":"Endothelin family peptides in human plasma and urine: their molecular forms and concentrations","volume":"15","author":"Matsumoto","year":"1994","journal-title":"Peptides"},{"key":"10.1016\/j.prp.2025.155932_bib35","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1124\/pr.115.011833","article-title":"Endothelin","volume":"68","author":"Davenport","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.prp.2025.155932_bib36","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0006-291X(02)02872-3","article-title":"Vasoactive intestinal contractor\/endothelin-2 gene expression in the murine central nervous system","volume":"300","author":"Masuo","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.prp.2025.155932_bib37","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1161\/01.RES.72.3.526","article-title":"Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium","volume":"72","author":"Molenaar","year":"1993","journal-title":"Circ. Res."},{"key":"10.1016\/j.prp.2025.155932_bib38","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.lfs.2014.02.020","article-title":"Modulation of endothelin receptors in the failing right ventricle of the heart and vasculature of the lung in human pulmonary arterial hypertension","volume":"118","author":"Kuc","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2025.155932_bib39","first-page":"270","article-title":"Upregulation of the endothelin ET(A) receptors in left ventricle from failing human hearts demonstrated using competition binding studies with FR139317","volume":"117","author":"Peter","year":"2014","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.prp.2025.155932_bib40","doi-asserted-by":"crossref","first-page":"D356","DOI":"10.1093\/nar\/gkv1178","article-title":"GPCRdb: an information system for G protein-coupled receptors","volume":"44","author":"Isberg","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.prp.2025.155932_bib41","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1126\/science.1071550","article-title":"G protein pathways","volume":"296","author":"Neves","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.prp.2025.155932_bib42","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1146\/annurev-physiol-030212-183750","article-title":"Mammalian phospholipase C","volume":"75","author":"Kadamur","year":"2013","journal-title":"Annu Rev. Physiol."},{"key":"10.1016\/j.prp.2025.155932_bib43","doi-asserted-by":"crossref","first-page":"12468","DOI":"10.1016\/S0021-9258(18)42300-9","article-title":"Coupling of two endothelin receptor subtypes to differing signal transduction in transfected Chinese hamster ovary cells","volume":"267","author":"Aramori","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prp.2025.155932_bib44","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0026-895X(24)12859-3","article-title":"Molecular mechanism for endothelin-1-induced stress-fiber formation: analysis of G proteins using a mutant endothelin(A) receptor","volume":"61","author":"Kawanabe","year":"2002","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.prp.2025.155932_bib45","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1242\/dev.012708","article-title":"Recombinase-mediated cassette exchange reveals the selective use of Gq\/G11-dependent and -independent endothelin 1\/endothelin type A receptor signaling in pharyngeal arch development","volume":"135","author":"Sato","year":"2008","journal-title":"Development"},{"key":"10.1016\/j.prp.2025.155932_bib46","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.1523\/JNEUROSCI.4828-12.2013","article-title":"GDNF and endothelin 3 regulate migration of enteric neural crest-derived cells via protein kinase A and Rac1","volume":"33","author":"Goto","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.prp.2025.155932_bib47","doi-asserted-by":"crossref","first-page":"S156","DOI":"10.1016\/j.ydbio.2018.08.014","article-title":"News from the endothelin-3\/EDNRB signaling pathway: Role during enteric nervous system development and involvement in neural crest-associated disorders","volume":"444","author":"Bondurand","year":"2018","journal-title":"Dev. Biol."},{"key":"10.1016\/j.prp.2025.155932_bib48","doi-asserted-by":"crossref","first-page":"S244","DOI":"10.1097\/00005344-200036051-00072","article-title":"Endothelin regulates angiotensin-converting enzyme in the mouse kidney","volume":"36","author":"Barton","year":"2000","journal-title":"J. Cardiovasc Pharm."},{"key":"10.1016\/j.prp.2025.155932_bib49","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1146\/annurev.pharmtox.41.1.851","article-title":"Endothelin system: the double-edged sword in health and disease","volume":"41","author":"Kedzierski","year":"2001","journal-title":"Annu Rev. Pharm. Toxicol."},{"key":"10.1016\/j.prp.2025.155932_bib50","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0031-6997(25)06809-7","article-title":"molecular biology, biochemistry, pharmacology, physiology, and pathophysiology","volume":"46","author":"Rubanyi","year":"1994","journal-title":"Pharm. Rev."},{"key":"10.1016\/j.prp.2025.155932_bib51","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S0140-6736(94)92827-4","article-title":"Contribution of endogenous generation of endothelin-1 to basal vascular tone","volume":"344","author":"Haynes","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.prp.2025.155932_bib52","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1161\/01.HYP.34.4.876","article-title":"State-of-the-Art lecture. Role of endothelin-1 in hypertension","volume":"34","author":"Schiffrin","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.prp.2025.155932_bib53","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1161\/01.CIR.93.6.1214","article-title":"Endogenous endothelin-1 participates in the maintenance of cardiac function in rats with congestive heart failure, Marked increase in endothelin-1 production in the failing heart","volume":"93","author":"Sakai","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.prp.2025.155932_bib54","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0014-2999(88)90106-9","article-title":"Endothelin, a novel vasoconstrictor peptide, as potent bronchoconstrictor","volume":"154","author":"Uchida","year":"1988","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.prp.2025.155932_bib55","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/ncpneph0891","article-title":"Reversal of proteinuric renal disease and the emerging role of endothelin","volume":"4","author":"Barton","year":"2008","journal-title":"Nat. Clin. Pr. Nephrol."},{"key":"10.1016\/j.prp.2025.155932_bib56","doi-asserted-by":"crossref","first-page":"378","DOI":"10.2337\/db07-0893","article-title":"Vascular peptide endothelin-1 links fat accumulation with alterations of visceral adipocyte lipolysis","volume":"57","author":"Harmelen van","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.prp.2025.155932_bib57","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1016\/j.molimm.2009.05.179","article-title":"TLR2 and TLR4 agonists induce production of the vasoactive peptide endothelin-1 by human dendritic cells","volume":"46","author":"Spirig","year":"2009","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.prp.2025.155932_bib58","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(23)01241-2","article-title":"Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches","volume":"402","author":"Heymans","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.prp.2025.155932_bib59","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/0002-9149(91)90511-I","article-title":"Plasma endothelin-1 levels in idiopathic dilated cardiomyopathy","volume":"68","author":"Hiroe","year":"1991","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.prp.2025.155932_bib60","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1042\/cs0900037","article-title":"Expression of endothelin peptides and mRNA in the human heart","volume":"90","author":"Plumpton","year":"1996","journal-title":"Clin. Sci. (Lond. )"},{"key":"10.1016\/j.prp.2025.155932_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169896","article-title":"Influence of mechanical circulatory support on endothelin receptor expression in human left ventricular myocardium from patients with Dilated Cardiomyopathy (DCM)","volume":"12","author":"G\u00e4rtner","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2025.155932_bib62","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.amjhyper.2006.06.016","article-title":"The G-231A polymorphism in the endothelin-A receptor gene is associated with lower aortic pressure in patients with dilated cardiomyopathy","volume":"20","author":"Telgmann","year":"2007","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.prp.2025.155932_bib63","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1053\/euhj.1999.1696","article-title":"Identification of a genetic risk factor for idiopathic dilated cardiomyopathy. Involvement of a polymorphism in the endothelin receptor type A gene","volume":"20","author":"Charron","year":"1999","journal-title":"CARDIGENE Group, Eur. Heart J."},{"key":"10.1016\/j.prp.2025.155932_bib64","doi-asserted-by":"crossref","first-page":"10428","DOI":"10.1158\/0008-5472.CAN-07-1344","article-title":"The endothelin receptor blocker bosentan inhibits doxorubicin-induced cardiomyopathy","volume":"67","author":"Bien","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.prp.2025.155932_bib65","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1161\/01.CIR.0000105701.98663.D4","article-title":"Conditional cardiac overexpression of endothelin-1 induces inflammation and dilated cardiomyopathy in mice","volume":"109","author":"Yang","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.prp.2025.155932_bib66","doi-asserted-by":"crossref","first-page":"R1399","DOI":"10.1152\/ajpregu.2001.280.5.R1399","article-title":"A novel pharmacological action of ET-1 to prevent the cytotoxicity of doxorubicin in cardiomyocytes","volume":"280","author":"Suzuki","year":"2001","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.prp.2025.155932_bib67","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bcp.2015.01.014","article-title":"Protective effects of endothelin receptor A and B inhibitors against doxorubicin-induced cardiomyopathy","volume":"94","author":"Schwebe","year":"2015","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.prp.2025.155932_bib68","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","article-title":"Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity","volume":"122","author":"Jia","year":"2018","journal-title":"Circ. Res"},{"key":"10.1016\/j.prp.2025.155932_bib69","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1161\/CIRCULATIONAHA.110.938217","article-title":"Endothelial cell-derived endothelin-1 promotes cardiac fibrosis in diabetic hearts through stimulation of endothelial-to-mesenchymal transition","volume":"121","author":"Widyantoro","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.prp.2025.155932_bib70","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1142\/S0192415X18500623","article-title":"Oleanolic acid, a novel endothelin A receptor antagonist, alleviated high glucose-induced cardiomyocytes injury","volume":"46","author":"Wu","year":"2018","journal-title":"Am. J. Chin. Med"},{"key":"10.1016\/j.prp.2025.155932_bib71","doi-asserted-by":"crossref","first-page":"13816","DOI":"10.3390\/ijms232213816","article-title":"High glucose-induced cardiomyocyte damage involves interplay between endothelin ET-1\/ETA\/ETB receptor and mTOR pathway","volume":"23","author":"Pandey","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.prp.2025.155932_bib72","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1016\/j.bbadis.2018.07.020","article-title":"Cardiomyocyte-specific knockout of endothelin receptor a attenuates obesity cardiomyopathy","volume":"1864","author":"Ceylan","year":"2018","journal-title":"Biochim Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.prp.2025.155932_bib73","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2015.01.019","article-title":"New perspectives on the prevalence of hypertrophic cardiomyopathy","volume":"65","author":"Semsarian","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.prp.2025.155932_bib74","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1161\/01.RES.69.1.209","article-title":"Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes","volume":"69","author":"Ito","year":"1991","journal-title":"Circ. Res"},{"key":"10.1016\/j.prp.2025.155932_bib75","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/0092-8674(93)90541-W","article-title":"Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro","volume":"75","author":"Sadoshima","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.prp.2025.155932_bib76","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1172\/JCI116579","article-title":"Endothelin-1 is an autocrine\/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes","volume":"92","author":"Ito","year":"1993","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.prp.2025.155932_bib77","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1161\/01.CIR.89.5.2198","article-title":"Endothelin ETA receptor antagonist blocks cardiac hypertrophy provoked by hemodynamic overload","volume":"89","author":"Ito","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.prp.2025.155932_bib78","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1161\/01.HYP.27.2.259","article-title":"Endothelin-1 and its receptor in hypertrophic cardiomyopathy","volume":"27","author":"Hasegawa","year":"1996","journal-title":"Hypertension"},{"issue":"2015","key":"10.1016\/j.prp.2025.155932_bib79","first-page":"2","article-title":"United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal disease","volume":"5","author":"Collins","year":"2011","journal-title":"Kidney Int Suppl."},{"key":"10.1016\/j.prp.2025.155932_bib80","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.semnephrol.2015.06.003","article-title":"Stroke and chronic kidney disease: epidemiology, pathogenesis, and management across kidney disease stages","volume":"35","author":"Dad","year":"2015","journal-title":"Semin Nephrol."},{"key":"10.1016\/j.prp.2025.155932_bib81","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/14728222.2017.1311864","article-title":"Sodium potassium adenosine triphosphatase (Na\/K-ATPase) as a therapeutic target for uremic cardiomyopathy","volume":"21","author":"Wang","year":"2017","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.prp.2025.155932_bib82","doi-asserted-by":"crossref","first-page":"S437","DOI":"10.1097\/00005344-199100177-00125","article-title":"Endothelin in patients with chronic renal failure","volume":"17","author":"Saito","year":"1991","journal-title":"J. Cardiovasc Pharm."},{"key":"10.1016\/j.prp.2025.155932_bib83","doi-asserted-by":"crossref","first-page":"S348","DOI":"10.1097\/00005344-200036051-00101","article-title":"Endothelin-receptor antagonists in uremic cardiomyopathy","volume":"36","author":"Wolf","year":"2000","journal-title":"J. Cardiovasc Pharm."},{"key":"10.1016\/j.prp.2025.155932_bib84","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0014-5793(93)81291-7","article-title":"Endothelin-1, phorbol esters and phenylephrine stimulate MAP kinase activities in ventricular cardiomyocytes","volume":"317","author":"Bogoyevitch","year":"1993","journal-title":"FEBS Lett."},{"key":"10.1016\/j.prp.2025.155932_bib85","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1146\/annurev.physiol.63.1.391","article-title":"Cytoplasmic signaling pathways that regulate cardiac hypertrophy","volume":"63","author":"Molkentin","year":"2001","journal-title":"Annu Rev. Physiol."},{"key":"10.1016\/j.prp.2025.155932_bib86","doi-asserted-by":"crossref","first-page":"276S","DOI":"10.1042\/CS103S276S","article-title":"Influence of endothelin receptor antagonists on myocardial protein kinase C isoforms in uraemic cardiomyopathy","volume":"103","author":"Wolf","year":"2002","journal-title":"Clin. Sci. (Lond. )"},{"key":"10.1016\/j.prp.2025.155932_bib87","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1161\/01.CIR.99.16.2171","article-title":"Role of endothelin in deterioration of heart failure due to cardiomyopathy in hamsters: increase in endothelin-1 production in the heart and beneficial effect of endothelin-A receptor antagonist on survival and cardiac function","volume":"99","author":"Yamauchi-Kohno","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.prp.2025.155932_bib88","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1161\/01.CIR.99.14.1802","article-title":"Functional effects of endothelin and regulation of endothelin receptors in isolated human nonfailing and failing myocardium","volume":"99","author":"Pieske","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.prp.2025.155932_bib89","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1254\/jjp.59.239","article-title":"Effect of endothelin (ET)-1, ET-3 and ET-(16-21) on the isolated and perfused rat kidney from normotensive and spontaneously hypertensive rats","volume":"59","author":"Evangelista","year":"1992","journal-title":"Jpn J. Pharm."},{"key":"10.1016\/j.prp.2025.155932_bib90","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12868-021-00646-z","article-title":"Brain size reductions associated with endothelin B receptor mutation, a cause of Hirschsprung's disease","volume":"22","author":"Chen","year":"2021","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.prp.2025.155932_bib91","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.cellsig.2017.04.010","article-title":"Endothelin-1 promotes hypertrophic remodelling of cardiac myocytes by activating sustained signalling and transcription downstream of endothelin type A receptors","volume":"36","author":"Archer","year":"2017","journal-title":"Cell Signal"},{"key":"10.1016\/j.prp.2025.155932_bib92","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12906-018-2206-9","article-title":"Puerarin inhibits vascular smooth muscle cells proliferation induced by fine particulate matter via suppressing of the p38 MAPK signaling pathway","volume":"18","author":"Wan","year":"2018","journal-title":"BMC Complement Alter. Med"},{"key":"10.1016\/j.prp.2025.155932_bib93","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2174\/138920305774933295","article-title":"Endothelin receptors in gastrointestinal smooth muscle","volume":"6","author":"Huang","year":"2005","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.prp.2025.155932_bib94","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0008-6363(98)00166-7","article-title":"Altered inotropic response of endothelin-1 in cardiomyocytes from rats with isoproterenol-induced cardiomyopathy","volume":"39","author":"Suzuki","year":"1998","journal-title":"Cardiovasc. Res."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825001244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825001244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T10:47:58Z","timestamp":1749206878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033825001244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":94,"alternative-id":["S0344033825001244"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2025.155932","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of endothelin and its receptors in cardiomyopathy: From molecular mechanisms to therapeutic insights","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2025.155932","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"155932"}}